Psychiatry Research
Volume 134, Issue 3 , Pages 241-250 , 30 April 2005

Comparisons between psychosis samples with different patterns of substance use recruited for clinical and epidemiological studies

  • Amanda Baker

      Affiliations

    • Centre for Mental Health Studies, University of Newcastle, University Drive, Callaghan, NSW 2308, Australia
    • Neuroscience Institute of Schizophrenia and Allied Disorders, The Garvan Institute, Darlinghurst, Sydney, NSW 2001, Australia
    • Corresponding Author InformationCorresponding author. Centre for Mental Health Studies, University of Newcastle, University Drive, Callaghan, NSW 2308, Australia. Tel.: +61 2 4924 6610; fax: +61 2 4924 6608.
    • ,
  • Sandra Bucci

      Affiliations

    • Centre for Mental Health Studies, University of Newcastle, University Drive, Callaghan, NSW 2308, Australia
    • ,
  • Terry J. Lewin

      Affiliations

    • Centre for Mental Health Studies, University of Newcastle, University Drive, Callaghan, NSW 2308, Australia
    • Neuroscience Institute of Schizophrenia and Allied Disorders, The Garvan Institute, Darlinghurst, Sydney, NSW 2001, Australia
    • ,
  • Robyn Richmond

      Affiliations

    • School of Public Health and Community Medicine, University of New South Wales, Sydney, NSW 2052, Australia
    • ,
  • Vaughan J. Carr

      Affiliations

    • Centre for Mental Health Studies, University of Newcastle, University Drive, Callaghan, NSW 2308, Australia
    • Neuroscience Institute of Schizophrenia and Allied Disorders, The Garvan Institute, Darlinghurst, Sydney, NSW 2001, Australia

Received 27 July 2004 ,Revised 23 February 2005 ,Accepted 24 February 2005.

References 

  1. Baker, A., Dawe, S., in press. Amphetamine use and co-occurring psychological disorders: a review of the literature and implications for treatment. Australian Psychologist.
  2. Baker A, Lewin T, Reichler H, Clancy R, Carr V, Garrett R, et al. Motivational interviewing among psychiatric in-patients with substance use disorders. Acta Psychiatrica Scandinavica. 2002;106:233–240
  3. Baker, A., Richmond, R., Haile, M., Lewin, T., Carr, V., Taylor, R., Constable, P., Jansons, S., Wilhelm, K., Moeller-Saxone, K., submitted for publication. Characteristics of smokers with a psychotic disorder and implications for smoking interventions. Psychiatry Research.
  4. Blow FC, Barry KL, BootsMiller BJ, Copeland LA, McCormick R, Visnic S. Longitudinal assessment of inpatient use and functioning of seriously mentally ill veterans with and without co-occurring substance use disorders. Journal of Psychiatric Research. 1998;32:311–319
  5. Brunette MF, Mueser KT, Xie H, Drake RE. Relationships between symptoms of schizophrenia and substance abuse. Journal of Nervous and Mental Disease. 1997;185:13–20
  6. Cantor-Graae E, Nordstrom LG, McNeil TF. Substance abuse in schizophrenia: a review of the literature and a study of correlates in Sweden. Schizophrenia Research. 2001;48:69–82
  7. Cantwell R. Substance use and schizophrenia: effects on symptoms, social functioning and service use. British Journal of Psychiatry. 2003;182:329
  8. Carey MP, Carey KB, Meisler AW. Psychiatric symptoms in mentally ill chemical abusers. Journal of Nervous and Mental Disease. 1991;179:136–138
  9. Carr VJ, Johnston PJ, Lewin TJ, Rajkumar S, Carter GL, Issakidis C. Patterns of service use among persons with schizophrenia and other psychotic disorders. Psychiatric Services. 2003;54:226–235
  10. Cassano GB, Pini S, Saettoni M, Rucci P, Dell'Osso L. Occurrence and clinical correlates of psychiatric comorbidity in patients with psychotic disorders. Journal of Clinical Psychiatry. 1998;59:60–68
  11. Darke S, Heather N, Hall W, Ward J, Wodak A. Estimating drug consumption in opioid users: reliability and validity of a ‘recent use’ episodes method. British Journal of Addiction. 1991;86:1311–1316
  12. De Leon J. Smoking and vulnerability for schizophrenia. Schizophrenia Bulletin. 1996;22:405–409
  13. Duke PJ, Pantelis C, McPhillips MA, Barnes TR. Comorbid non-alcohol substance misuse among people with schizophrenia: epidemiological study in central London. British Journal of Psychiatry. 2001;179:509–513
  14. Drake RE, McLaughlin P, Pepper B, Minkoff K. Dual diagnosis of major mental illness and substance disorder: an overview. New Directions for Mental Health Services. 1991;50:3–12
  15. First MB, Gibbon M, Spitzer RL, Williams JBW. Users Guide for the Structured Clinical Interview for DSM-IV Axis 1 Disorder—Research Version—(SCID-1, Version 2.0, February 1996). Biometrics Research Department. New York: New York State Psychiatric Institute; 2003;
  16. Fowler IL, Carr VJ, Carter NT, Lewin TJ. Patterns of current and lifetime substance use in schizophrenia. Schizophrenia Bulletin. 1998;24:443–455
  17. Goff DC, Henderson DC, Amico E. Cigarette smoking in schizophrenia: relationship to psychopathology and medication side effects. American Journal of Psychiatry. 1992;149:1189–1194
  18. Herran A, de Santiago A, Sandoya M, Fernandez MJ, Diez-Manrique JF, Vazquez-Barquero JL. Determinants of smoking behavior in outpatients with schizophrenia. Schizophrenia Research. 2000;41:373–381
  19. Hughes JR, Hatsukami DK, Mitchell JE, Dahlgren LA. Prevalence of smoking among psychiatric outpatients. American Journal of Psychiatry. 1986;143:993–997
  20. Jablensky A, McGrath J, Herrman H, Castle D, Gureje O, Evans M, et al. Psychotic disorders in urban areas: an overview of the study on low prevalence disorders. Australian and New Zealand Journal of Psychiatry. 2000;34:221–236
  21. Jenkins R. The national psychiatric morbidity surveys of Great Britain: initial findings from the household survey. Psychological Medicine. 1997;27:775–789
  22. Kavanagh DJ, Waghorn G, Jenner L, Chant DC, Carr V, Evans M, et al. Demographic and clinical correlates of comorbid substance use disorders in psychosis: multivariate analyses from an epidemiological sample. Schizophrenia Research. 2004;66:115–124
  23. Kovasznay B, Bromet E, Schwartz JE, Ram R, Lavelle J, Brandon L. Substance abuse and onset of psychotic illness. Hospital and Community Psychiatry. 1993;44:567–571
  24. Lawrence D, Holma D, Jablensky A. Preventable Physical Illness in People with Mental Illness. Perth: The University of Western Australia; 2001;
  25. Loughland CM, Carr VJ, Lewin TJ. The NISAD schizophrenia research register: why do we need a schizophrenia research database?. Australian and New Zealand Journal of Psychiatry. 2001;35:660–667
  26. Loughland CM, Carr VJ, Lewin TJ, Barnard RE, Chapman JL, Walton JM. Potential sampling and recruitment source impacts in schizophrenia research. Psychiatry Research. 2004;125:117–127
  27. Margolese HC, Malchy L, Negrete JC, Tempier R, Gill K. Drug and alcohol use among patients with schizophrenia and related psychoses: levels and consequences. Schizophrenia Research. 2004;67:157–166
  28. McCreadie RG, Sharkey V, Halliday J, MacDonald S, MacEwan T, Farrington S, et al. Use of drugs, alcohol and tobacco by people with schizophrenia: case control study. British Journal of Psychiatry. 2002;181:321–325
  29. McGuffin P, Farmer A, Harvey I. A polydiagnostic application of operational criteria in studies of psychotic illness. Development and reliability of the OPCRIT system. Archives of General Psychiatry. 1991;48:764–770
  30. Pols HG, Hawks DV. Is There a Safe Level of Daily Consumption of Alcohol for Men and Women?. Canberra: Australian Government Publishing Service; 1992;
  31. Regier DA, Farmer ME, Rae DS, Locke BZ, Keith SJ, Judd LL, et al. Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study. JAMA: The Journal of the American Medical Association. 1990;264:2511–2518
  32. Reichler H, Baker A, Lewin T, Carr V. Smoking among in-patients with drug-related problems in an Australian psychiatric hospital. Drug and Alcohol Review. 2001;20:231–237
  33. Siris SG. Depression in the course of schizophrenia. In:  Hwang MY,  Bermanzohn PC editor. Schizophrenia and Comorbid Conditions: Diagnosis and Treatment. Washington, DC: American Psychiatric Press; 2001;p. 31–56
  34. Spencer C, Castle D, Mitchie PT. Motivations that maintain substance use among individuals with psychotic disorders. Schizophrenia Bulletin. 2002;28:233–247
  35. Ventura J, Lukoff D, Nuechterlein KH, Liberman RP, Green M, Shaner A. Appendix 1: Brief Psychiatric Rating Scale (BPRS) expanded version (4.0) scales, anchor points and administration manual. International Journal of Methods in Psychiatric Research. 1993;3:227–243
  36. Wilhelm K. The relevance of smoking and nicotine to clinical psychiatry. Australasian Psychiatry. 1998;6:130–132
  37. World Health Organization . WHO Psychiatric Disability Assessment Schedule (WHO/DAS). Geneva: WHO; 1998;
  38. Zisook S, Heaton R, Moranville J, Kuck J, Jernigan T, Braff D. Past substance abuse and clinical course of schizophrenia. American Journal of Psychiatry. 1992;149:552–563

PII: S0165-1781(05)00060-0

doi: 10.1016/j.psychres.2005.02.006

Psychiatry Research
Volume 134, Issue 3 , Pages 241-250 , 30 April 2005

Article Tools